heart
[대역어] 심장
[용어속성] Term
[용어속성] Term
ActiGraph and Short-term Heart Rate Variability Study Protocol: Amended for the COVID-19 Pandemic
ActiGraph 및 단기 심박수 변동성 연구 프로토콜: COVID-19 전염병에 대해 수정됨
Article
[키워드] autonomic
Bluetooth
collected
collection time
Community
conjunction
correlation
COVID-19
COVID-19 pandemic
Data analysis
Data collection
enrolled
followed by
heart
heart disease
heart rate
hopelessness
HRV
ischemic heart disease
measure
minimum
modulation
MONITOR
Pandemics
participant
Patient
physical activity
protocol
Randomized controlled trial
Rate
Research
researcher
revision
Revisions
social distancing
Standardization
Study protocol
subsequent
Variability
[DOI] 10.1097/JCN.0000000000000817 PMC 바로가기 [Article Type] Article
[DOI] 10.1097/JCN.0000000000000817 PMC 바로가기 [Article Type] Article
COVID-19: The Cause of the Manifested Cardiovascular Complications During the Pandemic
Cardiovascular Medicine
[키워드] affected
affecting
blind
cardiac
cardiovascular
cardiovascular complication
cause
clinical recovery
Cohort
Complication
Course
COVID-19
CVD
decrease
disease
driven by
Effect
health care systems
healthy
heart
immunization
Impact
impacted
individuals
Infection
Inflammation
Manifestations
Measures
morbidities
myocardial damage
National
pandemic
Pandemics
pediatric
question
reported
SARS-CoV-2
significantly
Spread
stability
subsequent
Surveillance
the disease
virus
[DOI] 10.3389/fcvm.2021.744482 PMC 바로가기 [Article Type] Cardiovascular Medicine
[DOI] 10.3389/fcvm.2021.744482 PMC 바로가기 [Article Type] Cardiovascular Medicine
Whey-Derived Peptides at the Heart of the COVID-19 Pandemic
COVID-19 팬데믹의 중심에 있는 유청 유래 펩타이드
Article
[키워드] ACE
ACE inhibitor
ACE inhibitors
ACE inhibitory activity
ACE2
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
approach
association
blood pressure
blood pressure homeostasis
Captopril
cells
component
coronavirus
COVID-19
COVID-19 pandemic
drugs
dual
enzyme
exhibiting
heart
human ACE2
hypertension
inhibit
inhibitory
inhibitory action
inhibitory activity
IPP
Lisinopril
molecular docking
molecular interaction
peptide
peptide sequences
peptides
Previous studies
produced
RAS
RAS inhibitor
RAS inhibitors
receptor
reduced risk
renin–angiotensin system
renin–angiotensin system
reported
respiratory
SARS-CoV-2
sequence
severe acute respiratory syndrome Coronavirus
shown
synthetic drugs
therapeutic
Treatment
treatment of COVID-19
were assessed
whey peptides
[DOI] 10.3390/ijms222111662 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms222111662 PMC 바로가기 [Article Type] Article
Symptom Persistence Despite Improvement in Cardiopulmonary Health – Insights from longitudinal CMR, CPET and lung function testing post-COVID-19
Research article
[키워드] abnormality
Cardiopulmonary
CMR
comparable
Control
controls
coronavirus disease
COVID-19
CPET
Department
Ejection fraction
fibrosis
finding
follow-up assessment
foundation
funding
Health
heart
Hospitalised patients
impairment
IMPROVE
improvement
Infection
Innovation
insight
ISRCTN
Long COVID
lung
Lung function
magnetic resonance imaging
marker
measure
Measures
Medical Research Council
muscular
National
Native
NIHR
outcomes
Oxford
oxygen
parenchymal abnormality
Patient
patients
persistent
PHOSP-COVID
recruited
reduced
remained
Research
returned
SARS-CoV-2
spirometry
supported
Symptom
symptomatic
trajectory
United Kingdom
ventricular
Volume
Wellcome Trust
[DOI] 10.1016/j.eclinm.2021.101159 [Article Type] Research article
[DOI] 10.1016/j.eclinm.2021.101159 [Article Type] Research article
Cardiac Fibrosis Is a Risk Factor for Severe COVID-19
심장 섬유증은 심각한 COVID-19의 위험 요소입니다
Immunology
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
Analysis
biochemical analysis
Blood
cardiac
cellular
Clinical deterioration
Clinical outcome
Cohort
Contact
controls
coronavirus
coronavirus disease
Coronavirus disease 2019
correlated strongly
COVID-19
COVID-19 patients
Deceased
disease severity
echocardiographic
echocardiography
elevated
emergency department
explain
Factor
fibrosis
growth factor
heart
Increased
Infection
left
lung
Lungs
marker
matched controls
mRNA
mRNA level
mRNA levels
Myocardium
NRP-1
Patient
patients hospitalized
performed
predicted
Prevalence
pulmonary fibrosis
quantification
reported
respiratory
risk
risk factor
RNA
SARS-CoV-2
SARS-CoV-2 nucleocapsid
severe disease progression
sIL1
TGF-β1
TGF-β1
transforming growth factor
ventricular
Viral
viral entry
with COVID-19
[DOI] 10.3389/fimmu.2021.740260 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.740260 PMC 바로가기 [Article Type] Immunology
Functional Effects of Cardiomyocyte Injury in COVID-19
COVID-19에서 심근세포 손상의 기능적 효과
Cellular Response to Infection
[키워드] absence
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Affect
Analysis
Blood
cardiac disease
Cardiomyocytes
Cell
clinical
Clinical data
Clinical finding
Clinical findings
Comorbidities
Comorbidity
Computational biology
contractile
contractile apparatus
coronavirus
COVID-19
COVID-19 patient
COVID-19 patients
Culture
decrease
decreased expression
develop
disease
disorganization
dysfunction
echocardiography
Effect
elevated
Elevation
expression
Extracellular
healthy
heart
heart disease
heart tissue
hearts
hospitalized patient
hospitalized patients
identify
IL-1β
IL-10
IL-1β
IL-6
increase
infect
Infection
Injury
interleukin
Interleukins
Laboratory
machine learning
mechanism
Mount Sinai
Mount Sinai Health System
mRNA
multinucleated cells
multiple organs
NL63
observation
Patient
physiological
physiological change
physiological effect
physiological effects
pluripotent stem cell
Protein
reduced
respiratory
resulting
SARS-CoV-2
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
subject
subset
suppresse
System
Treatment
Trigger
triggers
troponin
troponin I
underlie
ventricular
ventricular ejection
Viral
viral infection
virus
virus infection
[DOI] 10.1128/JVI.01063-21 PMC 바로가기 [Article Type] Cellular Response to Infection
[DOI] 10.1128/JVI.01063-21 PMC 바로가기 [Article Type] Cellular Response to Infection
Development of the International Classification of Diseases Ontology (ICDO) and its application for COVID-19 diagnostic data analysis
국제 질병 분류 온톨로지 (ICDO)의 국제 분류 개발 및 COVID-19 진단 데이터 분석에 대한 적용
Research
[키워드] addressed
adopted
aligned
analyzed
annotations
applied
basic
bioinformatics
causes
characterization
Chinese
classification
clinical
components
country
COVID-19
COVID-19 disease
COVID-19 patient
Data analysis
dataset
defined
development
diabetes
Diagnosis
diagnostic
disease
Disease standardization
Diseases
EHR
English
etiological
Formal
health problems
heart
ICD
ICD10
ICD9
ICDO
International
kidney
Kidney disease
Kidney diseases
lung
mapped
Occurrence
ontologies
Ontology
organ
organs
other diseases
over
phenotype
platform
problem
profiles
provide
Result
reuse
Signs and symptoms
Symptoms
use case
website
[DOI] 10.1186/s12859-021-04402-2 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12859-021-04402-2 PMC 바로가기 [Article Type] Research
Diabetes, Heart Failure, and COVID-19: An Update
Physiology
[키워드] acute respiratory syndrome
affected
cardiovascular disease
Clinical finding
confirmed case
coronavirus
country
COVID
COVID-19
CVD (cardio vascular disease)
death
demonstrated
diabete
diabetes
diabetic cardio
disease
disease severity
failure
Focusing
globe
heart
heart failure
incidence
increase in
Intersection
long-COVID
pandemic
Pathologies
Patient
Patient care
potential mechanism
question
Research
SARS-CoV-2
SARS-COV-2 infection
the disease
the WHO
variant
while
[DOI] 10.3389/fphys.2021.706185 PMC 바로가기 [Article Type] Physiology
[DOI] 10.3389/fphys.2021.706185 PMC 바로가기 [Article Type] Physiology
Late Cardiac Pathology in Severe Covid-19. A Postmortem Series of 30 Patients
Cardiovascular Medicine
[키워드] adipose
alteration
Analysis
Arterial hypertension
Atherosclerosis
Autopsy
cardiac
Cardiac pathology
cardiovascular
cardiovascular condition
chronic heart failure
Cohort
Comorbidity
condition
COVID-19
death
died
disease
Evolution
heart
histological
histopathological finding
Hospital stay
hypertrophic cardiomyopathy
Infection
Inflammation
invasive
lesion
macroscopic
male
median age
median time
myocarditis
obesity
pathological finding
Patient
patients
performed
Postmortem
RNA
RT-PCR
SARS-CoV-2
Sery
severe COVID-19
symptoms onset
tissue samples
Two patient
valve replacement
ventricular
[DOI] 10.3389/fcvm.2021.748396 PMC 바로가기 [Article Type] Cardiovascular Medicine
[DOI] 10.3389/fcvm.2021.748396 PMC 바로가기 [Article Type] Cardiovascular Medicine